Capital Croissance
Also known as Capital Croissance SAS
Paris independent management company founded in 2012 backed by 600+ entrepreneur subscribers; runs buy-out, growth, impact VC and fund-of-funds strategies with €0.5–50M tickets.
- HEADQUARTERS
- Paris, France
- FOUNDED
- 2012
- AUM
- —
- OUTSIDE CAPITAL
- Yes
- TEAM LISTED
- 15 people
Focus
- STAGES
- SeedSeries ASeries BGrowthBuyout
- SECTORS
- Software & SaaSConsumer & E-commerceEducationIndustrial & ManufacturingMedia & EntertainmentHealthTechClimate & Energy
- ASSET MIX
- Private equityVenture capitalFunds (as LP)Impact
- GEOGRAPHY
- FranceEuropeAfrica
Investment arms & vehicles
- Buy-out and growth-capital club for French SMEs with €10–100M revenue; €285M, 300+ entrepreneur subscribers, launched 2013
- Buy-out and growth-capital club for SMEs with €5–30M revenue; €75M, 120+ entrepreneur subscribers, launched 2021
- €200M long-term programme (up to 15 years) backed by 14 families for French mid-caps with €50–250M revenue, launched 2019
- Fund-of-funds and co-investment strategy in European small and lower mid-cap buyouts, active since 2008
- Impact venture capital arm (ex-MAIF Avenir), seed to Series A in Europe
- Impact VC fund for decentralised renewable energy in emerging markets, mainly sub-Saharan Africa; managed by Capital Croissance since 2023
- Capital Croissance endowment fund (philanthropy)
Overview
Capital Croissance is an independent, AMF-authorised management company created in 2012 that invests equity and quasi-equity in French, European and international start-ups, SMEs and mid-caps. Its funds are subscribed by more than 600 entrepreneurs, executives, investment professionals and families, organised in business clubs: CAIRN (SMEs), Edelweiss (smaller growth companies) and K2 (mid-caps, 14 families). It also runs impact venture capital through Ternel (Europe) and Gaia Impact (emerging markets), a fund-of-funds and co-investment strategy (Bluester), and an endowment fund, Ouréa. The team numbers about fifty people.
Investment thesis
Growth and transfer transactions in profitable SMEs and mid-caps of all sectors (revenue €5–250M, tickets €1M to more than €25M) as reference shareholder; seed-to-Series A impact venture in Europe (€0.5–5M) and in emerging markets; European lower mid-market LBO exposure through fund commitments and co-investments (€3–5M).
PORTFOLIO (8)
- EquativNOTABLEMedia & Entertainment · since 2021
- BonsoirsConsumer & E-commerce · since 2026
- SerapidIndustrial & Manufacturing · since 2025
- Cube EducationEducation · since 2025
- TravelsoftSoftware & SaaS · since 2024
- StidIndustrial & Manufacturing · since 2024
- iDealwineConsumer & E-commerce · since 2021
- BiobankHealthTech · since 2014
People
- Eric NeuplancheFounding President (Président Fondateur) · source
- Maxime PeronninDirecteur Général · source
- Sophie PeyroutetSecrétaire Générale · source
- Fabrice FleuryManaging Partner, CAIRN · source
- Julie MassonManaging Partner, CAIRN · source
- Julien Berger-PerrinManaging Partner, CAIRN · source
- Benjamin PersynManaging Partner, K2 · source
- Arnaud TardanManaging Partner, K2 · source
- Christophe JadotManaging Partner, Edelweiss · source
- Antoine HouëlManaging Partner, Edelweiss · source
- Mohamed AbdesslamManaging Partner, Ternel · source
- Hélène DemaegdtPresident & Founder, Gaia Impact · source
- Victor BeulqueManaging Partner, Gaia Impact · source
- Anne-Sophie KerfournManaging Partner, Bluester · source
- Arnaud BurelManaging Partner, Bluester · source
Links
Frequently asked questions
Capital Croissance is a private equity fund based in Paris, France, founded in 2012.
Yes. Capital Croissance invests its own capital in private companies.
Capital Croissance invests at Seed, Series A, Series B, Growth and Buyout stages in Software & SaaS, Consumer & E-commerce, Education, Industrial & Manufacturing, Media & Entertainment, HealthTech and Climate & Energy.
Capital Croissance's stated ticket size is €500K–€50M.
Key people at Capital Croissance include Eric Neuplanche (Founding President (Président Fondateur)), Maxime Peronnin (Directeur Général), Sophie Peyroutet (Secrétaire Générale) and Fabrice Fleury (Managing Partner, CAIRN).
Capital Croissance's investments include Equativ, Bonsoirs, Serapid, Cube Education, Travelsoft, Stid, iDealwine and Biobank.
The most recent publicly reported investment by Capital Croissance is Bonsoirs (Minority secondary MBO (Edelweiss Croissance I)), announced in Sep 2026.
Yes. Capital Croissance manages capital from outside investors.